Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VEEVA SYSTEMS INC.

(VEEV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Veeva : Industry Leaders Share Strategies to Optimize RIM Performance at Veeva R&D and Quality Summit Connect

06/17/2021 | 03:58am EDT

This year we hosted more than 1,600 attendees at the Veeva R&D and Quality Summit Connect for a day of innovation, collaboration, and new product announcements.

In the regulatory track, more than a dozen Vault RIM customers shared their experiences and best practices for transforming regulatory operations. One of the highlights was a panel discussion with Recordati, GE Healthcare, and Mundipharma on how to get maximum benefit from a RIM solution. The panelists talked about harmonizing and streamlining regulatory processes; measuring and improving performance with KPIs; and the critical role of change management and data governance in realizing business value.

Faster Time-to-Market with Unified Processes
Emma Forrest, head of global R&D operations at Recordati, described their transition from siloed operations and outsourced services to a centralized, operationally efficient hub that manages submissions and other regulatory activities. By unifying regulatory processes, Recordati has accelerated the delivery of acquired products to market and saved more than a million dollars annually. Forrest stressed the role that KPIs have played in promoting the adoption and success of their Vault RIM implementation. 'It's critical to demonstrate that the system is making a difference to management, business heads, and operational teams,' she stated. 'They all benefit from seeing overall progress.'

New Metrics Enable Ongoing Efficiency Gains
James Hendry, head of global regulatory operations at GE Healthcare, shared his team's success driving business process improvements with monthly reporting on eight standard KPIs. For example, the organization is now 90% compliant with a 10-day target for communicating regulatory approvals, up from 40% when tracking started. GE Healthcare also prioritized data governance to increase the value derived from their RIM implementation. 'It's been put into everybody's top-level goals in the QRA organization to improve the quality of data in the Veeva system,' Hendry said. 'This system is the source of truth, so the data needs to be up-to-date and correct.'

Laying the Groundwork to Optimize RIM Performance
Mundipharma is at the beginning of a journey to harmonize and streamline regulatory processes across RX, CX, and local product portfolios. Helen Donnelly, head of RA systems and analytics, detailed the steps the company is taking to increase RIM value realization in the run-up to launch. These efforts include defining as-is and to-be processes, configuring the system to report and maximize efficiencies, and addressing 'the human element' of change management. 'We're driving that process and data ownership now, so by the time we go live with Veeva some of those behaviors are already embedded in the team,' Donnelly said.

Many thanks to our panelists for sharing their insights and experiences. To view this and other sessions from the Summit's regulatory track, please visit the Veeva R&D and Quality Summit Connect hub. If you'd like to learn more about how Veeva can help you get the most out of your RIM system, contact katrin.spaepen@veeva.com.

Disclaimer

Veeva Systems Inc. published this content on 16 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 June 2021 07:57:05 UTC.


ę Publicnow 2021
All news about VEEVA SYSTEMS INC.
07/27VEEVA : Enhancing HCP Engagement With a Hybrid Events Strategy
PU
07/21VEEVA : Royal Bank of Canada Initiates Veeva Systems at Outperform With $400 Pri..
MT
07/15MODERNIZING REGULATORY AFFAIRS : Veeva MedTech Regulatory Benchmark Study
PU
07/15VEEVA : Biopharma Leaders Pioneering a Digital-First Future for Commercial
PU
07/14VEEVA : How Biopharma Leaders are Shifting to Hybrid Engagement
PU
07/09VEEVA : Lessons from Vericel on Streamlining Medical Information Management
PU
07/06VEEVA : Cutting Through the Noise With Predictive Pharmacovigilance
PU
07/06INSIDER TRENDS : Veeva Systems Insider Exercises Option/Derivative Security to A..
MT
07/06INSIDER TRENDS : Insider at Veeva Systems Acquires Stock Via Option/Derivative S..
MT
07/02VEEVA : How Life Sciences' Shift to Digital is Improving Collaboration and Patie..
PU
More news
Financials (USD)
Sales 2022 1 823 M - -
Net income 2022 443 M - -
Net cash 2022 2 406 M - -
P/E ratio 2022 119x
Yield 2022 -
Capitalization 50 784 M 50 784 M -
EV / Sales 2022 26,5x
EV / Sales 2023 21,9x
Nbr of Employees 4 506
Free-Float 89,7%
Chart VEEVA SYSTEMS INC.
Duration : Period :
Veeva Systems Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VEEVA SYSTEMS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 332,10 $
Average target price 334,57 $
Spread / Average Target 0,74%
EPS Revisions
Managers and Directors
Peter P. Gassner Chief Executive Officer & Director
Tom Schwenger President & Chief Operating Officer
Brent Bowman Chief Financial Officer
Gordon Ritter Chairman
Catherine Allshouse Global Chief Information Officer & Head-Operations
Sector and Competitors
1st jan.Capi. (M$)
VEEVA SYSTEMS INC.21.98%49 917
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-54.15%17 523
OMNICELL, INC.26.10%6 536
PRO MEDICUS LIMITED64.61%4 409
CLOVER HEALTH INVESTMENTS, CORP.-52.00%3 285
SECTRA AB (PUBL)-6.34%3 076